Author:
Díaz Bessone María Ines,Berardi Damian E.,Campodónico Paola B.,Todaro Laura B.,Lothstein Leonard,Bal de Kier Joffé Elisa D.,Urtreger Alejandro J.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Roaten JB, Kazanietz MG, Sweatman TW et al (2001) Molecular models of N-benzyladriamycin-14-valerate (AD 198) in complex with the phorbol ester-binding C1b domain of protein kinase C-delta. J Med Chem 44:1028–1034
2. Bilyeu JD, Panta GR, Cavin LG et al (2004) Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines. Mol Pharmacol 65:1038–1047
3. Roaten JB, Kazanietz MG, Caloca MJ et al (2002) Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity. Mol Cancer Ther 1:483–492
4. Lothstein L, Rodrigues PJ, Sweatman TW et al (1998) Cytotoxicity and intracellular biotransformation of N-benzyladriamycin-14-valerate (AD 198) are modulated by changes in 14-O-acyl chain length. Anticancer Drugs 9:58–66
5. Dekker LV, Parker PJ (1994) Protein kinase C—a question of specificity. Trends Biochem Sci 19:73–77
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献